Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer

DANIEL KREJČÍ, ADAM ŠUBRT, PETR OPÁLKA, JANA KREJČÍ, MONIKA ŠIBALOVÁ, MARTIN SVATOŇ, MILOSLAV PÁLA, PETRA TESAŘOVÁ and NORBERT PAUK
Anticancer Research December 2025, 45 (12) 5579-5586; DOI: https://doi.org/10.21873/anticanres.17892
DANIEL KREJČÍ
1Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
2Institute of Radiation Oncology, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dannykrejci{at}seznam.cz
ADAM ŠUBRT
2Institute of Radiation Oncology, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETR OPÁLKA
1Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANA KREJČÍ
1Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MONIKA ŠIBALOVÁ
3Institute of Biostatistics and Analyses Ltd., Brno, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN SVATOŇ
4Department of Pneumology and Phthisiology, Faculty of Medicine, Charles University, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILOSLAV PÁLA
2Institute of Radiation Oncology, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETRA TESAŘOVÁ
2Institute of Radiation Oncology, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORBERT PAUK
1Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 45 no. 12 5579-5586
DOI 
https://doi.org/10.21873/anticanres.17892
PMID 
41318117

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 9, 2025
  • Revision received September 27, 2025
  • Accepted October 1, 2025
  • Published online November 29, 2025.

Copyright & Usage 
Copyright © 2025 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. DANIEL KREJČÍ1,2⇑,
  2. ADAM ŠUBRT2,
  3. PETR OPÁLKA1,
  4. JANA KREJČÍ1,
  5. MONIKA ŠIBALOVÁ3,
  6. MARTIN SVATOŇ4,
  7. MILOSLAV PÁLA2,
  8. PETRA TESAŘOVÁ2 and
  9. NORBERT PAUK1
  1. 1Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  2. 2Institute of Radiation Oncology, First Faculty of Medicine, Charles University, Bulovka University Hospital, Prague, Czech Republic;
  3. 3Institute of Biostatistics and Analyses Ltd., Brno, Czech Republic;
  4. 4Department of Pneumology and Phthisiology, Faculty of Medicine, Charles University, Pilsen, Czech Republic
  1. Daniel Krejčí, Department of Pneumology, Third Faculty of Medicine, Charles University, Bulovka University Hospital, Budínova 67/2, Prague 8, 182 00, Czech Republic. Tel: +42 0266082267, e-mail: dannykrejci{at}seznam.cz
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 45 (12)
Anticancer Research
Vol. 45, Issue 12
December 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer
DANIEL KREJČÍ, ADAM ŠUBRT, PETR OPÁLKA, JANA KREJČÍ, MONIKA ŠIBALOVÁ, MARTIN SVATOŇ, MILOSLAV PÁLA, PETRA TESAŘOVÁ, NORBERT PAUK
Anticancer Research Dec 2025, 45 (12) 5579-5586; DOI: 10.21873/anticanres.17892

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer
DANIEL KREJČÍ, ADAM ŠUBRT, PETR OPÁLKA, JANA KREJČÍ, MONIKA ŠIBALOVÁ, MARTIN SVATOŇ, MILOSLAV PÁLA, PETRA TESAŘOVÁ, NORBERT PAUK
Anticancer Research Dec 2025, 45 (12) 5579-5586; DOI: 10.21873/anticanres.17892
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study
  • Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab
  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
Show more Clinical Studies

Keywords

  • NSCLC
  • BMI
  • immunotherapy
  • immune checkpoint inhibitors
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire